New EU Approvals
Executive Summary
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to include five new products, including Roche’s Enspryng for neuromyelitis optica spectrum disorder.
You may also be interested in...
Roche Among EU Fast-Track Hopefuls With Lymphoma Bispecific Mosunetuzumab
Two companies are set to learn whether the European Medicines Agency will agree that their planned EU marketing applications merit an accelerated assessment.
Amgen Strikes Early-Access Deal In England For Lung Cancer Drug Lumakras
Patients in England with non-small cell lung cancer will be the first In Europe to be offered Amgen’s KRAS G12C inhibitor.
England’s NICE To Find New Chief As Leng Announces Retirement
The top job at the National Institute for Health and Care Excellence has been described as one of the most challenging and potentially controversial roles in British public life.